Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

267
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
267
Tissue Transplantation01:24

Tissue Transplantation

319
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
319

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Transplantation: Webcast June 5 2025.

Methodist DeBakey cardiovascular journal·2025
Same author

Multimodal Cardiac Imaging of Immune-Mediated Complications Post Heart Transplantation: A Contemporary Review.

Journal of the American Heart Association·2025
Same author

Extracorporeal Life Support for Cardiogenic Shock in Adult Congenital Heart Disease-An ELSO Registry Analysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2023
Same author

Coronary Allograft Vasculopathy: From Predictably Unpredictable to Unpredictably Predictable.

Circulation. Heart failure·2023
Same author

Single-Nuclear RNA Sequencing of Endomyocardial Biopsies Identifies Persistence of Donor-Recipient Chimerism With Distinct Signatures in Severe Cardiac Allograft Vasculopathy.

Circulation. Heart failure·2022

Related Experiment Video

Updated: May 21, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.3K

Expanding the Donor Pool.

Saleem Toro1, Kelly H Schlendorf1

  • 1Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, US.

Methodist Debakey Cardiovascular Journal
|May 19, 2025
PubMed
Summary

The demand for heart transplants is rising due to an aging population. Strategies like using hepatitis C virus-infected donors and improved organ preservation aim to expand the donor pool and address the organ shortage.

Keywords:
DCDNRPheart transplantationhepatitis Corgan donororgan preservationtransplant policy

More Related Videos

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.1K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

8.8K

Related Experiment Videos

Last Updated: May 21, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.3K
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.1K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

8.8K

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Public Health Policy

Background:

  • The number of patients with advanced heart failure requiring heart transplantation is increasing.
  • Current heart transplantation therapies face a persistent gap between organ demand and supply.
  • An aging population exacerbates the need for viable organ donors.

Purpose of the Study:

  • To review current strategies for expanding the donor pool for heart transplantation.
  • To address the persistent mismatch between organ demand and supply.
  • To explore innovative approaches to increase the availability of donor hearts.

Main Methods:

  • Review of existing and emerging strategies for donor pool expansion.
  • Analysis of transplantation protocols involving hepatitis C virus-infected donors.
  • Evaluation of organ preservation technologies.
  • Assessment of public education and national donation policies' impact.

Main Results:

  • Transplantation from hepatitis C virus-infected donors offers a viable option.
  • Donors after circulatory death (DCD) present an expanded source of organs.
  • Advanced organ preservation techniques can salvage hearts previously deemed unsuitable.
  • Public education and policy changes can positively influence donation rates.

Conclusions:

  • Multiple strategies are being actively pursued to increase the availability of donor hearts.
  • Innovative approaches are crucial to meet the growing demand for heart transplantation.
  • A multi-faceted approach involving medical advancements and policy reform is necessary to bridge the organ donor gap.